Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Conditions:   Recurrent Lung Non-Small Cell Carcinoma;   Stage IV Lung Cancer AJCC v8 Interventions:   Procedure: Biospecimen Collection;   Procedure: Computed Tomography;   Procedure: Lymphoscintigraphy;   Procedure: Magnetic Resonance Imaging;   Biological: Ramucirumab;   Drug: Tepotinib Sponsors:   SWOG Cancer Research Network;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials